Filing Details
- Accession Number:
- 0000927066-24-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-23 17:44:01
- Reporting Period:
- 2024-02-21
- Accepted Time:
- 2024-02-23 17:44:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 927066 | Davita Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640409 | Alyce Kathleen Waters | C/O Davita Inc. 2000 16Th Street Denver CO 80202 | Chief Legal & Pub. Affairs Off | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-21 | 40,000 | $52.41 | 121,297 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-21 | 17,044 | $123.00 | 104,253 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2024-02-21 | 11,671 | $123.00 | 92,582 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-02-21 | 11,285 | $120.73 | 81,297 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2024-02-21 | 40,000 | $0.00 | 40,000 | $52.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-06-20 | 2024-06-20 | No | 4 | M | Direct |
Footnotes
- Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
- Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
- Represents the weighted average sale price of $120.73. The range of prices for the sale of these shares was $120.09 - $122.02 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023.
Billionaire Hedge Funds
